| TTM
|
12/31/2025
|
12/31/2024
|
12/31/2023
|
12/31/2022
|
|
|---|---|---|---|---|---|
| Total Revenue
|
0 | 0 | 0 | 0 | 0 |
| Selling, General and Administrative Expenses
|
-3,207.9840 | -1,388.5090 | -2,110.7310 | -2,651.0030 | -1,158.7730 |
|
Research and Development Expenses
|
-482.9580 | -454 | -112.3370 | -1,149.2090 | -1,277.7680 |
| Depreciation, Amortization and Depletion
|
-14.8720 | -11.5440 | -7.9500 | -8.2850 | -3.6440 |
|
Operating Income/Expenses
|
-3,705.8140 | -1,854.0530 | -2,231.0180 | -3,808.4970 | -2,440.1850 |
|
Total Operating Profit/Loss
|
-3,705.8140 | -1,854.0530 | -2,231.0180 | -3,808.4970 | -2,440.1850 |
| Total Net Finance Income/Expense
|
-236.1230 | -186.1900 | -770.3610 | -541.8280 | -526.3210 |
| Net Investment Income
|
314.2720 | -216.7010 | 133.1210 | 0 | -- |
| Irregular Income/Expenses
|
133.8670 | 133.8670 | 488.2530 | -212.4580 | 0 |
|
Other Income/Expense, Non-Operating
|
-- | -- | -- | -- | 300 |
|
Non-Operating Income/Expenses, Total
|
212.0160 | -269.0240 | -148.9870 | -754.2860 | -226.3210 |
|
Pretax Income
|
-3,493.7990 | -2,123.0770 | -2,380.0050 | -4,562.7830 | -2,666.5060 |
|
Provision for Income Tax
|
0 | 0 | 0 | 0 | 0 |
|
Net Income from Continuing Operations
|
-3,493.7990 | -2,123.0770 | -2,380.0050 | -4,562.7830 | -2,666.5060 |
|
Net Income after Extraordinary Items and Discontinued Operations
|
-3,493.7990 | -2,123.0770 | -2,380.0050 | -4,562.7830 | -2,666.5060 |
|
Non-Controlling/Minority Interests
|
0 | 0 | 13.3240 | 90.2580 | 193.3720 |
|
Net Income after Non-Controlling/Minority Interests
|
-3,493.7990 | -2,123.0770 | -2,366.6810 | -4,472.5250 | -2,473.1340 |
|
Net Income Available to Common Stockholders
|
-3,493.7990 | -2,123.0770 | -2,366.6810 | -4,472.5250 | -2,473.1340 |
|
Diluted Net Income Available to Common Stockholders
|
-3,493.7990 | -2,123.0770 | -2,366.6810 | -4,472.5250 | -2,473.1340 |
| Basic EPS
|
-0.02 | -0.02 | -0.02 | -0.03 | -0.02 |
| Diluted EPS
|
-0.02 | -0.02 | -0.02 | -0.03 | -0.02 |
|
Basic Weighted Average Shares Outstanding
|
104,096.6830 | 91,843.4090 | 138,598.6910 | 133,973.3520 | 112,712.3050 |
|
Diluted Weighted Average Shares Outstanding
|
104,096.6830 | 91,843.4090 | 138,598.6910 | 133,973.3520 | 112,712.3050 |
| Income Statement, Supplemental
|
|||||
|
EBIT
|
-3,257.6760 | -1,936.8870 | -1,609.6440 | -4,020.9550 | -2,140.1850 |
|
EBITDA
|
-3,240.2950 | -1,925.3430 | -1,601.6940 | -4,012.6700 | -2,136.5410 |
|
Normalized EBITDA
|
-2,225.8900 | -1,464.8220 | -1,784.7580 | -3,622.7910 | -1,958.1590 |
|
Normalized Income
|
-2,479.3940 | -1,662.5560 | -2,563.0690 | -4,172.9040 | -2,488.1240 |
|
Total Unusual Items
|
1,014.4050 | 460.5210 | -183.0640 | 389.8790 | 178.3820 |
|
Total Unusual Items Excluding Goodwill
|
1,014.4050 | 460.5210 | -183.0640 | 389.8790 | 178.3820 |
12/31/2022 - 1/5/2010
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
Upgrade